French Aerospace & Defense Stock News

If you are wondering whether Sanofi is quietly turning into a bargain while everyone is focused on flashier names, this deep dive will help you assess whether the current price reflects its long term potential. Despite a solid 5 year gain of 28.1%, the stock is down 12.7% year to date and 4.6% over the last month, suggesting that sentiment has cooled even as the long term story remains intact. Recently, markets have been reacting to Sanofi's strategic shifts in its pharmaceutical pipeline...

If you are wondering whether LVMH Moët Hennessy Louis Vuitton Société Européenne is still a quality luxury name at a fair price, you are not alone. That is exactly what we are going to unpack here. The share price has been relatively steady but slightly positive, up around 1.2% over the last week and 3.6% over the past month, while sitting roughly flat year to date and modestly higher over 1 year. This hints at cautious optimism rather than a runaway rally. Recent headlines have focused on...

Wondering if Publicis Groupe is quietly turning into a value opportunity, or if the market has already priced in the upside? The stock has edged up about 1.5% over the last week and 5.5% over the past month, even though it is still down roughly 13.9% year to date and 10.2% over the last year after a very strong 3 and 5 year run. Recent headlines have focused on Publicis tightening its focus on high margin data and tech led services and securing new global client mandates, reinforcing its...

74Software (74SW) has quietly put up a strong run this year, with the stock gaining nearly 50% year to date, supported by steady revenue expansion and faster growing profits. See our latest analysis for 74Software. The recent rally has been driven more by a reappraisal of 74Software’s growth prospects than any single headline, with a 12.82 percent 1 month share price return adding to an already impressive 49.43 percent year to date share price gain and strong multi year total shareholder...

Wondering if Getlink is quietly becoming good value, or if the recent price leaves little upside on the table? Let us unpack what the market is really pricing into this cross Channel operator. The share price has edged up 1.4% over the last week and 1.0% over the last month, yet it is still roughly flat year to date at -0.6%, with a steadier 4.9% gain over the past year. Recent headlines have focused on traffic recovery through the Channel Tunnel and ongoing infrastructure investment plans...

Wondering if TotalEnergies is still a smart buy at today’s price, or if most of the upside has already been captured? Let us break down what the current share price is really implying about its long term value. The stock has been relatively steady in the short term, up 0.4% over the last week and 0.7% over the past month, but it has quietly delivered a solid 3.9% year to date and 14.3% over the last year, on top of a 110.6% gain across five years. Recent share price resilience has come as...

With the business potentially at an important milestone, we thought we'd take a closer look at Amoéba S.A.'s...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll...

Median Technologies SA ( EPA:ALMDT ) shareholders would be excited to see that the share price has had a great month...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider NSC...

Safran (ENXTPA:SAF) has quietly added to its strong run this year, with the stock edging higher over the past week and sitting on roughly 43% gains year to date. See our latest analysis for Safran. That latest move takes Safran’s share price to about €306.3, capping a strong year in which the share price return and longer term total shareholder returns suggest momentum is still building rather than fading. If Safran’s run has you rethinking your aerospace exposure, this could be a good moment...

DBV Technologies recently reported that its Phase 3 VITESSE trial of the VIASKIN Peanut patch for peanut‑allergic children aged 4–7 met its primary endpoint with statistically significant efficacy and a favorable safety profile, and the company now plans to submit a Biologics License Application to the US FDA in the first half of 2026. An important angle for investors is that this late-stage success follows earlier regulatory setbacks, suggesting the redesigned patch and trial design may...

In July 2025, Laura Burdese took over as CEO of Bulgari, succeeding long-time leader Jean-Christophe Babin, who remains chairman and head of the Bulgari Hotel business unit. This leadership reshuffle at one of LVMH’s key jewelry and hospitality brands could subtly reshape how the group balances heritage with expansion. We’ll now explore how Burdese’s appointment at Bulgari might influence LVMH’s broader investment narrative, especially around brand diversification and luxury hospitality. The...

Recent reports show that resale premiums for Hermès Birkin and Kelly bags have cooled from very large multiples of original prices to lower levels, even as luxury asset manager LUXUS, backed by Christie’s, launches new handbag investment funds focused on these models. This mix of softer secondary-market pricing and financialization of Hermès icons highlights how the brand now sits at the intersection of consumer demand, collectibles culture, and alternative investments. We’ll now examine how...

If you are wondering whether Atos at around €46 is a turnaround bargain or a value trap, you are not the only one. That is exactly what this breakdown is going to tackle. The stock has swung hard lately, down 15.9% over the last week but still up 6.0% over 30 days, with an eye catching 85.8% gain year to date and a 121.2% rise over the past year after a brutal multi year slide. Those moves come after years of restructuring and strategic shifts that have investors rethinking the long term...

If you are wondering whether BNP Paribas is still good value after a strong run, you are not alone. This article is going to unpack what is really priced into the shares today. The stock has climbed to around €80.24, with returns of 2.0% over the last week, 20.3% over the last month, 35.4% year to date and an impressive 52.8% over the past year. This naturally raises the question of how much upside might be left. Recently, the market has focused on BNP Paribas strategic push in European...

Recent Performance and Context STMicroelectronics (ENXTPA:STMPA) has been drifting in a tight range, with the stock roughly flat over the past week but up about 14% this month, even as its past 3 months remain negative. See our latest analysis for STMicroelectronics. Zooming out, STMicroelectronics has had a choppy ride, with the recent 13.68% 1 month share price return offering a partial rebound against a weaker year to date share price trend and negative multi year total shareholder...

As the European market experiences mixed movements, with indices such as Germany's DAX gaining while others like France's CAC 40 see declines, investors are keeping a close eye on potential policy shifts from the European Central Bank. In this environment of economic resilience and cautious optimism, dividend stocks can offer stability and income, making them an attractive consideration for those looking to navigate these uncertain times.

Pernod Ricard (ENXTPA:RI) has had a rough year in the market, with the share price slipping almost 30% year to date, even as revenues and net income are still inching higher. See our latest analysis for Pernod Ricard. That slump contrasts with a modest 1 week share price return of 1.9%, suggesting bargain hunters are testing the waters even as the 1 year total shareholder return of negative 25.3% shows momentum has clearly faded over a longer stretch. If you are reassessing your portfolio...

Getlink (ENXTPA:GET) has been drifting in a tight range recently, and that kind of quiet tape often hides useful clues. Let us dig into what the latest returns suggest about sentiment and value. See our latest analysis for Getlink. Zooming out, the share price has been broadly range bound this year, yet a positive 1 year total shareholder return of 4.6 percent suggests the market still sees steady, if unspectacular, progress rather than a sharp re rating. If Getlink has you thinking about...

As the European markets navigate mixed performances, with indices like Germany’s DAX gaining slightly and others such as France’s CAC 40 experiencing declines, investors are closely watching policy signals from the European Central Bank. In this context, penny stocks—often representing smaller or newer companies—remain a relevant investment area despite their somewhat outdated label. This article will explore three noteworthy penny stocks in Europe that may offer unique opportunities by...

As European markets navigate mixed signals with some indices like Germany's DAX showing gains while others such as France’s CAC 40 Index face declines, investors are keeping a close eye on economic indicators and central bank policies that could influence small-cap performance. In this environment, identifying promising small-cap stocks requires a keen understanding of how these companies can leverage current market conditions to their advantage, particularly in sectors poised for growth...

As the European market experiences a mix of gains and losses, with Germany's DAX showing positive momentum while France's CAC 40 and the UK's FTSE 100 see slight declines, investors are closely watching the European Central Bank's potential rate hikes amid resilient economic indicators. In this fluctuating environment, dividend stocks can offer a stable income stream, making them an attractive option for those seeking to balance growth with regular returns.